Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells

Journal of Immunology

Volumn 173, Issue 9, 2004, Pages 5835-5842

  Riemekasten, Gabriela ^a   Langnickel, Dirk ^a   Enghard, Philipp ^a   Undeutsch, Reinmar ^a   Humrich, Jens ^a   Ebling, Fanny M ^b   Hocher, Berthold ^a   Humaljoki, Tiina ^a   Neumayer, Hans ^a   Burmester, Gerd R ^a   Hahn, Bevra H ^b   Radbruch, Andreas ^c   Hiepe, Falk ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CYTOKINE; D1 PROTEIN; DNA ANTIBODY; DOUBLE STRANDED DNA; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; NUCLEOPROTEIN; PROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMD1 83 119 PROTEIN; SMITH PROTEIN; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MEGADOSE; FEMALE; GENE EXPRESSION; HELPER CELL; HISTOLOGY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 6344268942     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.9.5835     Document Type: Article

References (41)

1. Tan, E. M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immun. 44:93.
2. Bruns, A., S. Bläss, G. Hausdorf, G. R. Burmester, and F. Hiepe. 2000. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 43:230.
3. Riemekasten, G., J. Marell, G. Trebeljahr, R. Klein, G. Hausdorf, T. Häupl, J. Schneider-Mergener, G. R. Burmester, and F. Hiepe. 1998. A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J. Clin. Invest. 102:714.
4. Kaliyaperumal, A., M. A. Michaels, and S. K. Datta. 1999. Ag-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. J. Immunol. 1162:1775.
5. Talken, B. L., K. R. Shafermeyer, C. W. Bailey, E. R. Lee, and R. W. Hoffman. 2001. T cell epitope mapping of the Smith antigen reveals that highly conserved Smith antigen motifs are dominant target of T cell immunity in systemic lupus erythematosus. J. Immunol. 167:562.
6. 83-119 C-terminal peptide in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 61:779.
7. 83-119-reactive T cells that give T cell help for pathogenic anti-dsDNA antibodies. Arthritis Rheum. 48:475.
8. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367.
9. Lu, L., A. Kaliyaperumal, D. T. Boumpas, and S. K. Datta. 1999. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J. Clin. Invest. 104:345.
10. Madaio, M. P., and J. Club. 2000. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. Am. J. Kidney Dis. 35:992.
11. Ehl, S., P. Aichele, H. Ramseier, W. Bardlet, J. Hombach, H. Pircher, H. Hengartner, and R. M. Zinkernagel. 1998. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection. Nat. Med. 4:1015.
12. Gregorian, S. K., L. Clark, E. Heber-Katz, E. P. Amento, and A. Rostami. 1993. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis. Cell. Immunol. 150:298.
13. Jacobs, M. J., A. E. van den Hoek, L. B. van de Putte, and W. B. van den Berg. 1994. Anergy of antigen-specific T lymphocytes is a potent mechanism of intravenously induced tolerance. Immunology 82:294.
14. Billiard, B., E. S. Ventura, and A. Rostami. 1999. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis. Mult. Scler. 5:2.
15. Hahn, B..H., R. R. Singh, W. K. Wong, B. P. Tsao, K. Bulpitt, and F. M. Ebling. 2001. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus. Arthritis Rheum. 44:432.
16. Singh, R. R, F. M. Ebling, D. A. Albuquerque, V. Saxena, V. Kumar, E. H. Giannini, T. N. Marion, F. D. Finkelman, and B. H. Hahn. 2002. Induction of autoantibody production is limited in nonautoimmune mice. J. Immunol. 169:587.
17. Atherton, E. 1989. Solid Phase Peptide Synthesis: A Practical Approach. IRL Press, Oxford.
18. Riemekasten, G., A. Kawald, C. Weiss, A. Meine, J. Marell, R. Klein, B. Hocher, C. Meisel, G. Hausdorf, R. Manz, et al. 2001. Strong acceleration of murine lupus by injection of the SmD1 83-119 peptide. Arthritis Rheum. 44:2435.
19. Hiepe, F., S. Kiessig, S. Jahn, H. D. Volk, R. Grunow, E. Apostoloff, and R. von Baehr. 1986. A sensitive and class specific solid phase enzyme immunoassay for anti-DNA autoantibodies in supernatants of lymphocytes cultures and human hybridomas. Biomed. Biochem. Acta 45:K29.
20. Assenmacher, M., J. Schmitz, and A. Radbruch. 1994. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon- and in interleukin-4-expressing cells. Eur. J. Immunol. 24:1097.
21. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp. Med. 195:603.
22. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177:627.
23. Hafler, D. A., and H. L. Weiner. 1995. Immunologic mechanisms and therapy in multiple sclerosis. Immunol Rev. 144:75.
24. Brand, D. D., L. K. Myers, K. W. Whittington, K. A. Lathan, J. M. Stuart, A. H. Kang, and E. F. Rosloniec. 2002. Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model. J. Immunol. 168:490.
25. + T cells. Immunology 97:466.
26. Tang, H., and H. Braley-Mullen. 1997. Intravenous administration of deaggregated mouse thyreoglobulin suppress induction of experimental autoimmune thyreoiditis and expression of both Th1 and Th2 cytokines. Int. Immunol. 9:679.
27. Ohtsuko, K., J. D. Gray, M. M. Stimmler, B. Toro, and D. A. Horwitz. 1998. Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 160:2539.
28. Del Prete, G., M. De Carli, F. Almerigogna, M. G. Giudizi, R. Biagiotti, and S. Romagnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353.
29. Trinchieri, G. 2001. Regulatory role of T cells producing both Interferon γ and interleukin 10 in persistent infection. J. Exp. Med. 194:53.
30. + T cell clones producing both interferon-γ and interleukin-10 predominate in bronchoalveolar lavage of active pulmonary tuberculosis patients. Clin. Immunol. 92:224.
31. Pohl-Koppe, A., K. E. Balashov, A. C. Steer, E. L. Logigian, and D. A. Hafler. 1998. Identification of a T cell subset capable of both IFN-γ and IL-10 secretion pattern in patients with chronic Borrelia borgdorferi infection. J. Immunol. 160:1804.
32. + T regulatory cells suppress naïve and memory T cell proliferation and can be expanded in vitro without a loss of function. J. Exp. Med. 193:1295.
33. Horwitz, D. A. J. D. Gray, and S. G. Zheng. 2002. The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases. Arthritis Res. 4:241.
34. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the IL-10 receptor. Annu. Rev. Immunol. 19:683.
35. Chang, D. M., W. L. Su, and S. L. Chu. 2002. The expression and significance of intracellular T helper cytokines in systemic lupus erythematosus. Immunol. Invest. 31:1.
36. Tyrrell-Price, J., P. M. Lydyard, and D. A. Isenberg. 2001. The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 124:118.
37. Llorente, L., W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. Morel-Fourrier, J. C. Brouet, D. Alarcon-Segovia, P. Galanaud, et al. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:839.
38. 1 mice. J. Exp. Med. 179:305.
39. Yin, Z., G. Bahtiyar, N. Zhang, L. Liu, P. Zhu, M. E. Robert, J. McNiff, M. P. Madaio, and J. Craft. 2002. IL-10 regulates murine lupus. J. Immunol. 169:2148.
40. Morel, L., and E. K. Wakeland. 1998. Susceptibility to lupus nephritis in the NZB/W model system. Curr. Opin. Immunol. 10:718.
41. Manz, R. A., and A. Radbruch. 2002. Plasma cells for a lifetime? Eur. J. Immunol. 32:923.